Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia-Reference-Cited by-同舟云学术

Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia

Published:2019-08-13 Issue:12 Volume:42 Page:1923-1931
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Sakuma Masashi,Toyoda Shigeru,Hashimoto Ryouta,Yazawa Hiroko,Masuyama Taiki,Hirose Suguru,Waku Ryutaro,Hasumi Hisashi,Numao Toshiyuki,Abe Shichiro,Inoue Teruo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/s41440-019-0308-5.pdf

Reference34 articles.

1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C.Cholesterol Treatment Trialists’ (CTT) Collaborators et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–78.

2. Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–81.

3. Inoue T, Node K. Statin therapy for vascular failure. Cardiovasc Drug Ther. 2007;21:281–95.

4. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–504.

5. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I.Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group et al. High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005;294:2437–45.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia;The Korean Journal of Internal Medicine;2023-11-01

2. Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease;American Journal of Cardiovascular Drugs;2023-03-22

3. The effect of combination therapy with statins and ezetimibe on proinflammatory cytokines: A systematic review and meta-analysis of randomized controlled trials;International Immunopharmacology;2022-12

4. Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk;International Journal of Molecular Sciences;2022-11-04

5. The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials;Inflammopharmacology;2022-08-21